Search

Your search keyword '"Lubinski J"' showing total 1,408 results

Search Constraints

Start Over You searched for: Author "Lubinski J" Remove constraint Author: "Lubinski J"
1,408 results on '"Lubinski J"'

Search Results

101. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

102. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

103. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

104. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

105. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

106. Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes

107. Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome

108. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

109. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

110. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

111. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

112. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

113. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

114. Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts

115. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

116. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

117. Prognostic gene expression signature for high-grade serous ovarian cancer

118. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

119. Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation

120. CHEK2 is a multiorgan cancer susceptibility gene

123. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies

124. The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) – Results of an international collaborative study

125. Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study

129. Shared heritability and functional enrichment across six solid cancers (vol 10, 431, 2019)

130. Overlapping genetic architecture between Parkinson disease and melanoma

131. Two truncating variants in FANCC and breast cancer risk

132. Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes

133. Genome-wide association study of germline variants and breast cancer-specific mortality

134. Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways (vol 9, 4774, 2018)

135. Germline variation at 8q24 and prostate cancer risk in men of European ancestry (vol 9, 4616, 2018)

136. Genome-wide association study of germline variants and breast cancer-specific mortality

137. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

138. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis

140. XPD common variants and their association with melanoma and breast cancer risk

142. A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer

143. A common variant of CDKN2A (p16) predisposes to breast cancer

145. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

146. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

147. Correction to: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (Nature Genetics, (2018), 50, 7, (928-936), 10.1038/s41588-018-0142-8).

148. Shared heritability and functional enrichment across six solid cancers.

149. Genome-wide association study of germline variants and breast cancer-specific mortality.

150. Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4).

Catalog

Books, media, physical & digital resources